Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6195)
All Articles published online
|
Publishing Process of This Article
|
Nov 21, 2020 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Muzica CM, Stanciu C, Huiban L, Singeap AM, Sfarti C, Zenovia S, Cojocariu C, Trifan A. Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end. World J Gastroenterol 2020; 26(43): 6770-6781 [PMID: 33268960 DOI: 10.3748/wjg.v26.i43.6770] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i43/6770.htm |
| Number | Citing Articles |
| 1 |
Pietro Torre, Andrea Aglitti, Mario Masarone, Marcello Persico. Viral hepatitis: Milestones, unresolved issues, and future goals. World Journal of Gastroenterology 2021; 27(28): 4603-4638 doi: 10.3748/wjg.v27.i28.4603
|
| 2 |
Galal Yahya, Nashwa Hashem Mohamed, Jordi Pijuan, Noura M. Seleem, Rasha Mosbah, Steffen Hess, Ahmed A. Abdelmoaty, Rafa Almeer, Mohamed M. Abdel‐Daim, Hamoud Shulaywih Alshaman, Ibrahim Juraiby, Kamel Metwally, Zuzana Storchova. Profiling the physiological pitfalls of anti‐hepatitis C direct‐acting agents in budding yeast. Microbial Biotechnology 2021; 14(5): 2199 doi: 10.1111/1751-7915.13904
|
| 3 |
Cristina Maria Muzica, Carol Stanciu, Cristina Cijevschi-Prelipcean, Irina Girleanu, Laura Huiban, Oana Cristina Petrea, Ana-Maria Singeap, Camelia Cojocariu, Tudor Cuciureanu, Catalin Sfarti, Sebastian Zenovia, Stefan Chriac, Gabriela Stefanescu, Irina Ciortescu, Corina Lupașcu-Ursulescu, Egidia Miftode, Anca Trifan. Long-term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus Infection. Hepatitis Monthly 2021; 21(6) doi: 10.5812/hepatmon.115910
|
| 4 |
Ester Badia Aranda, Cristina Fernández Marcos, Aida Puebla Maestu, Visitación Gozalo Marín, Raquel Vinuesa Campo, Sara Calvo Simal, Judith Gómez Camarero. Evolución de los pacientes con infección crónica por hepatitis C con fibrosis avanzada o cirrosis curados con antivirales de acción directa. Seguimiento a largo plazo. Gastroenterología y Hepatología 2022; 45(10): 767 doi: 10.1016/j.gastrohep.2022.02.002
|
| 5 |
Nancy Abdel Fattah Ahmed, Ahmed Shawky Hassan Ali, Rizk Ahmed El Baz, Islam Abd El-Hamid El-Zayyadi. IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00102-x
|
| 6 |
Patricia Holanda Almeida, Celso E L Matielo, Lilian A Curvelo, Rodrigo A Rocco, Guilherme Felga, Bianca Della Guardia, Yuri L Boteon. Update on the management and treatment of viral hepatitis. World Journal of Gastroenterology 2021; 27(23): 3249-3261 doi: 10.3748/wjg.v27.i23.3249
|
| 7 |
Moustafa Sarhan, Alaa M. H. El-Bitar, Amaal Mohammadein, Mohammed Elshehaby, Hak Hotta. Virucidal activity of oriental hornet Vespa orientalis venom against hepatitis C virus. Journal of Venomous Animals and Toxins including Tropical Diseases 2021; 27 doi: 10.1590/1678-9199-jvatitd-2021-0039
|
| 8 |
Jennifer O. Lam, Leo B. Hurley, Jennifer B. Lai, Varun Saxena, Suk Seo, Scott Chamberland, Charles P. Quesenberry, Jamila H. Champsi, Joanna Ready, Elizabeth Y. Chiao, Julia L. Marcus, Michael J. Silverberg. Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals. Cancer Epidemiology, Biomarkers & Prevention 2021; 30(12): 2188 doi: 10.1158/1055-9965.EPI-21-0742
|
| 9 |
Lixia Qiu, Shanshan Xu, Yundong Qiu, Yali Liu, Jing Zhang. Comparison of acknowledged hepatocellular carcinoma risk scores in high‐risk hepatitis C patients with sustained virological response. Journal of Viral Hepatitis 2023; 30(6): 559 doi: 10.1111/jvh.13829
|
| 10 |
Ashraf M. Muhammad, Ghada M. Salum, Mai Abd El Meguid, Basma E. Fotouh, Reham M. Dawood. Bioinformatics analysis of multi-epitope peptide vaccines against Hepatitis C virus: a molecular docking study. Journal of Genetic Engineering and Biotechnology 2023; 21(1): 117 doi: 10.1186/s43141-023-00583-w
|
| 11 |
Sarah El-Nakeep. Molecular and genetic markers in hepatocellular carcinoma: <i>In silico </i>analysis to clinical validation (current limitations and future promises). World Journal of Gastrointestinal Pathophysiology 2022; 13(1): 1-14 doi: 10.4291/wjgp.v13.i1.1
|
| 12 |
Lidia Elżbieta Sierpińska. Concept of Health in Opinions of Patients Diagnosed with Hepatitis C. American Journal of Health Behavior 2022; 46(6): 643 doi: 10.5993/AJHB.46.6.7
|
| 13 |
Farinaz Forouzannia, Abdullah Hamadeh, Ana Maria Passos‐Castilho, Aysegul Erman, Amanda Yu, Zeny Feng, Naveed Z. Janjua, Beate Sander, Christina Greenaway, William W. L. Wong. Impact of new direct‐acting antiviral therapy on the prevalence and undiagnosed proportion of chronic hepatitis C infection. Liver International 2024; doi: 10.1111/liv.15875
|
| 14 |
Ester Badia Aranda, Cristina Fernández Marcos, Aida Puebla Maestu, Visitación Gozalo Marín, Raquel Vinuesa Campo, Sara Calvo Simal, Judith Gómez Camarero. Evolution of patients with chronic hepatitis C infection with advanced fibrosis or cirrhosis cured with direct-acting antivirals. Long-term follow-up. Gastroenterología y Hepatología (English Edition) 2022; 45(10): 767 doi: 10.1016/j.gastre.2022.02.005
|
| 15 |
Walaa Abdelhamed, Mohamed El‐Kassas. Hepatocellular carcinoma and hepatitis C virus treatments: The bold and the beautiful. Journal of Viral Hepatitis 2023; 30(2): 148 doi: 10.1111/jvh.13778
|
| 16 |
Saleh A. Alqahtani, Massimo Colombo. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma. Cells 2021; 10(11): 3091 doi: 10.3390/cells10113091
|
| 17 |
Shashank Kumar, Abhay Kumar Pandey. Potential Molecular Targeted Therapy for Unresectable Hepatocellular Carcinoma. Current Oncology 2023; 30(2): 1363 doi: 10.3390/curroncol30020105
|
| 18 |
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers 2021; 13(10): 2485 doi: 10.3390/cancers13102485
|
| 19 |
Faten Farouk, Ibrahim M. Ibrahim, Salma Sherif, Heba Gamal Abdelhamed, Marwa Sharaky, Ahmed A. Al‐Karmalawy. Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays. Chemical Biology & Drug Design 2024; 103(3) doi: 10.1111/cbdd.14500
|
| 20 |
Farina M Hanif, Zain Majid, Nasir Hassan Luck, Abbas Ali Tasneem, Syed Muddasir Laeeq, Muhammed Mubarak. Revolution in the diagnosis and management of hepatitis C virus infection in current era. World Journal of Hepatology 2022; 14(4): 647-669 doi: 10.4254/wjh.v14.i4.647
|
| 21 |
Zeev Elkoshi. The Eradication of Carcinogenic Viruses in Established Solid Cancers. Journal of Inflammation Research 2023; : 6227 doi: 10.2147/JIR.S430315
|
| 22 |
Tiffany Khoo, Danielle Lam, John K Olynyk. Impact of modern antiviral therapy of chronic hepatitis B and C on clinical outcomes of liver disease. World Journal of Gastroenterology 2021; 27(29): 4831-4845 doi: 10.3748/wjg.v27.i29.4831
|
| 23 |
Hideki Hagiwara, Yoshiki Ito, Takashi Ohta, Yasutoshi Nozaki, Takayuki Iwamoto, Atsushi Hosui, Naoki Hiramatsu, Yuki Tahata, Ryotaro Sakamori, Hayato Hikita, Norio Hayashi. Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct‐acting antiviral agents among the working population in Japan. JGH Open 2022; 6(6): 395 doi: 10.1002/jgh3.12745
|
| 24 |
María B Pisano, Cecilia G Giadans, Diego M Flichman, Viviana E Ré, María V Preciado, Pamela Valva. Viral hepatitis update: Progress and perspectives . World Journal of Gastroenterology 2021; 27(26): 4018-4044 doi: 10.3748/wjg.v27.i26.4018
|
| 25 |
Sung-Shuo Kao, Chia-Jung Li, James Cheng-Chung Wei, Cheng-Li Lin, Renin Chang, Yao-Min Hung. Human Papillomavirus Infection Is Associated with Decreased Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients: Taiwan Nationwide Matched Cohort Study. Cancers 2022; 14(5): 1289 doi: 10.3390/cancers14051289
|